KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Notes Payables: 2014

Historic Notes Payables for Biocryst Pharmaceuticals (BCRX) over the last 1 years, with Dec 2014 value amounting to $30.0 million.

  • Biocryst Pharmaceuticals' Notes Payables was N/A to $30.0 million in Q4 2014 from the same period last year, while for Dec 2014 it was $30.0 million, marking a year-over-year change of. This contributed to the annual value of $30.0 million for FY2014, which is N/A change from last year.
  • Biocryst Pharmaceuticals' Notes Payables amounted to $30.0 million in Q4 2014, which was down 0.00% from $30.0 million recorded in Q3 2014.
  • Biocryst Pharmaceuticals' Notes Payables' 5-year high stood at $30.0 million during Q2 2014, with a 5-year trough of $30.0 million in Q2 2014.
  • For the 1-year period, Biocryst Pharmaceuticals' Notes Payables averaged around $30.0 million, with its median value being $30.0 million (2014).